# Nucleome Therapeutics funding: rounds and investors

> Nucleome Therapeutics has raised $66M across 2 rounds since 2022. Investors include Creative Destruction Lab and Oxford Science Enterprises.

Source: https://millionrounds.com/company/nucleome-therapeutics (Millionrounds; every figure on the page links to its filing or article)

United Kingdom · [Series A startup](https://millionrounds.com/companies)

# Who invested in *Nucleome Therapeutics*

2 rounds we have observed, with the 2 investors named in them. Every figure came from a named source, and where the company reported a raise to the SEC itself, that is shown beside it.

Biotech

Funding summary Updated 26 Oct 2026

**$66M** raised across 2 rounds since 2022, from 2 sources

**$42M** Series A **$24M** Series A

- **Latest round:** Series A, $24M Jul 2024
- **Biggest round:** $42M Series A · Oct 2022
- **Investors:** 2

See who backed them

## The funding story

Each circle is a round, placed by date and sized by amount. The line above is the running total.

2023 2024

**$42M** Series A

**$24M** Series A

- **First round:** Series A, $42M
- **Biggest round:** $42M
- **Between rounds:** 21 months

## The rounds

- **Jul 2024** Series A **$24M** No investor was named in the report. Shares issued, filed with Companies House (SH01); no report of this raise yet
- **Oct 2022** Series A **$42M** *2 new* [Creative Destruction Lab](https://millionrounds.com/fund/creative-destruction-lab) [Oxford Science Enterprises](https://millionrounds.com/fund/oxford-science-enterprises) Source recorded

## Funding filed with regulators

Nucleome Therapeutics filed one raise, $24M in all. Filings say how much was sold and to how many investors; they never name the investors.

- Jul 2024 **$24M** UK share allotment

## Who was in which round

The busiest backers across the latest rounds. A filled square is a round they joined; a dark one, a round they led.

**Series A** 2022 **Series A** 2024 [Creative Destruction Lab](https://millionrounds.com/fund/creative-destruction-lab) [Oxford Science Enterprises](https://millionrounds.com/fund/oxford-science-enterprises)

## Everyone who backed them

[Creative Destruction Lab](https://millionrounds.com/fund/creative-destruction-lab) Accelerator **1** round

[Oxford Science Enterprises](https://millionrounds.com/fund/oxford-science-enterprises) VC firm **1** round

Missing a round, or an investor who was in one? [Tell us](https://millionrounds.com/corrections?slug=nucleome-therapeutics).

## Quick answers about Nucleome Therapeutics

### Who invested in Nucleome Therapeutics?

Nucleome Therapeutics's investors include Creative Destruction Lab and Oxford Science Enterprises.

### How much has Nucleome Therapeutics raised?

Nucleome Therapeutics has raised $66M across 2 rounds since 2022.

### When did Nucleome Therapeutics last raise?

Nucleome Therapeutics's most recent round was a Series A of $24M in Jul 2024.

### What was Nucleome Therapeutics's biggest round?

Nucleome Therapeutics's largest round on record is $42M (Series A), in Oct 2022.

### Who backed Nucleome Therapeutics first?

Nucleome Therapeutics's first round on record, in Oct 2022, was backed by Creative Destruction Lab and Oxford Science Enterprises.

### What stage is Nucleome Therapeutics at?

Nucleome Therapeutics's latest named round is a Series A, in Jul 2024.

### Where is Nucleome Therapeutics based?

Nucleome Therapeutics is based in the United Kingdom.

## Companies like Nucleome Therapeutics

In the same sector, and raised in the last eighteen months.

[**HydRegen** $12M · Oct 2026](https://millionrounds.com/company/hydregen)[**OMass Therapeutics** $442M · Oct 2026](https://millionrounds.com/company/omass-therapeutics)[**CMR Surgical** $1.1B · Oct 2026](https://millionrounds.com/company/cmr-surgical)[**Living Optics** $61M · Oct 2026](https://millionrounds.com/company/living-optics)[**Bactobio** $18M · Oct 2026](https://millionrounds.com/company/bactobio)[**RHYTHM AI** $23M · Sept 2026](https://millionrounds.com/company/rhythm-ai)

## Find investors like these

Search every investor by what they have actually funded, then narrow to your stage and market. Free.

Open the investor searchOr these rounds in the app